Recognition of divergent viral substrates by the SARS-CoV-2 main protease
EA MacDonald, G Frey, MN Namchuk… - ACS infectious …, 2021 - ACS Publications
The main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
[HTML][HTML] Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
EA MacDonald, G Frey, MN Namchuk… - ACS infectious …, 2021 - ncbi.nlm.nih.gov
The main protease (M pro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
[HTML][HTML] Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
EA MacDonald, G Frey, MN Namchuk, SC Harrison… - 2021 - europepmc.org
The main protease (M pro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
EA MacDonald, G Frey, MN Namchuk… - ACS infectious …, 2021 - pubmed.ncbi.nlm.nih.gov
The main protease (M pro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
EA MacDonald - 2021 - dlib.hust.edu.vn
The main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
[引用][C] Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
EA MacDonald, G Frey, MN Namchuk, SC Harrison… - ACS Infect. Dis., 2021 - osti.gov
[引用][C] Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
EA MacDonald, G Frey, MN Namchuk… - ACS Infectious …, 2021 - cir.nii.ac.jp
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF][PDF] Recognition of Divergent Viral Substrates by the SARS-CoV‑2 Main Protease
EA MacDonald, G Frey, MN Namchuk, SC Harrison… - stephenmhinshaw.com
The main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
EA MacDonald, G Frey, MN Namchuk, SC Harrison… - bioRxiv, 2021 - biorxiv.org
The main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
[PDF][PDF] Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease
EA MacDonald, G Frey, MN Namchuk, SC Harrison… - scholar.archive.org
The main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …
2), the cause of coronavirus disease (COVID-19), is an ideal target for pharmaceutical …